(3)Application for the renewal of the approval of the active substance penthiopyrad was submitted in accordance with Commission Implementing Regulation (EU) 2020/1740note. On 19 January 2023, the rapporteur Member State informed the co-rapporteur Member States, the Commission and the Authority that they had assessed the admissibility pursuant to Article 8 of Implementing Regulation (EU) 2020/1740, and in particular the completeness and the timeliness, of the application and concluded that it was admissible.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.